Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma [2]

Neurology

Volumn 74, Issue 16, 2010, Pages 1329-1330

  Jaeckle, Kurt A ^a   Ballman, Karla ^a   Furth, Alfred ^a   Buckner, Jan C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DEXAMETHASONE; ENZYME INDUCING AGENT; METHYLPREDNISOLONE; NITROSOUREA; PHENYTOIN; ANTINEOPLASTIC AGENT; ENZYME;

CANCER CELL; CANCER RADIOTHERAPY; CLINICAL TRIAL; GLIOBLASTOMA; HUMAN; LETTER; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME; CANCER CHEMOTHERAPY; CANCER SURGERY; DRUG METABOLISM; DRUG PROTEIN BINDING; EPILEPSY; PROPHYLAXIS; BLOOD; BRAIN TUMOR; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; ENZYME ACTIVATION; EPIDEMIOLOGY; META ANALYSIS; METABOLISM; MORTALITY; NOTE; PHYSIOLOGY; REPRODUCIBILITY; SURVIVAL RATE;

ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BIAS (EPIDEMIOLOGY); BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYMES; GLIOBLASTOMA; HUMANS; META-ANALYSIS AS TOPIC; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77951469433     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d8a5ed     Document Type: Letter

References (10)

1. Jaeckle KA, Ballman K, Furth A, Buckner JC. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology 2009;73:1207-1213.
2. Rüegg S. Dexamethasone/phenytoin interactions: neuroon-cological concerns. Swiss Med Wkly 2002;132:425-426.
3. van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumors. Epidemiology, mechanisms, and management Lancet Neurol 2007;6:421-430.
4. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameters: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886-1893.
5. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007;297:278-285.
6. Hwang SL, Lin CL, Lee KS, et al. Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir 2004;146:589-594.
7. Rosati A, Tomassini A, Pollo B, et al. Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol 2009;93:395-400.
8. Green SB, Byar DP, Walker MD, et al. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67:121-132.
9. Fine HA, Dear KB, Loeffler JS, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-2597.
10. Weber GF, Waxman DJ. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by micro-somal glutathione S-transferase and cytochrome P450 mono-oxygenases. Arch Biochem Biophys 1993;307:369-378.